Tag Archives: Hematology

Soliris (Eculizumab) Concentrated Solution Alexion Recall

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Soliris (Eculizumab) Concentrated Solution for Intravenous Infusion by Alexion: Recall – Visible Particles AUDIENCE: Hematology, Pharmacy ISSUE: Alexion Pharmaceuticals, Inc. is providing information regarding a previously communicated voluntary recall … Continue reading

Share
Posted in FDA 2013, FDA Recall, Hematology, Pharmacy | Tagged , , , , , , , , , | Comments Off

Omontys peginesatide Injection by Affymax and Takeda Recall

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseOmontys (peginesatide) Injection by Affymax and Takeda: Recall of All Lots – Serious Hypersensitivity Reactions AUDIENCE: Patients, Healthcare Professionals, Hematology ISSUE: Affymax, Inc. and Takeda Pharmaceutical Company Limited along with … Continue reading

Share
Posted in FDA 2013, FDA Recall, Healthcare Professionals, Hematology, Patients | Tagged , , , , , , , , , , , | Comments Off

Pradaxa (dabigatran etexilate mesylate) Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChinesePradaxa (dabigatran etexilate mesylate): Drug Safety Communication – Safety Review of Post-Market Reports of Serious Bleeding Events AUDIENCE: Cardiology, Pharmacy, Hematology ISSUE: FDA is evaluating post-marketing reports of serious bleeding … Continue reading

Share
Posted in Cardiology, FDA 2011, FDA Notice, FDA Warning, Hematology, Pharmacy | Tagged , , , , , , , , , | Comments Off

Sprycel (dasatinib) Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseSprycel (dasatinib): Drug Safety Communication – Risk of Pulmonary Arterial Hypertension AUDIENCE: Hematology, Oncology ISSUE: FDA notified healthcare professionals that Sprycel (dasatinib) may increase the risk of a rare but … Continue reading

Share
Posted in FDA 2011, FDA Notice, Hematology, Oncology | Tagged , , , , , , | Comments Off